{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:50:06Z","timestamp":1778176206412,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.cgh.2018.01.021","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T11:44:27Z","timestamp":1517399067000},"page":"1569-1584.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9437-4163","authenticated-orcid":false,"given":"Judy","family":"Nee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Zakari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Sugarman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4014-1954","authenticated-orcid":false,"given":"Julia","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahnaz","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6746-1958","authenticated-orcid":false,"given":"Sarah","family":"Ballou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Iturrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Lembo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2018.01.021_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MCG.0000000000000246","article-title":"Definitions and outcome measures of clinical trials regarding opioid-induced constipation: a systematic review","volume":"49","author":"Gaertner","year":"2015","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2018.01.021_bib2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.cgh.2018.01.021_bib3","doi-asserted-by":"crossref","first-page":"R1046","DOI":"10.1186\/ar1782","article-title":"Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids","volume":"7","author":"Moore","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cgh.2018.01.021_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4637.2008.00495.x","article-title":"The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)","volume":"10","author":"Bell","year":"2009","journal-title":"Pain Med"},{"key":"10.1016\/j.cgh.2018.01.021_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/15360280903098440","article-title":"Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy","volume":"23","author":"Candrilli","year":"2009","journal-title":"J\u00a0Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.cgh.2018.01.021_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003495-200363070-00003","article-title":"Opioid-induced bowel dysfunction: pathophysiology and potential new therapies","volume":"63","author":"Kurz","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.cgh.2018.01.021_bib7","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/ajg.2013.169","article-title":"Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis","volume":"108","author":"Ford","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2018.01.021_bib8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cgh.2018.01.021_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2018.01.021_bib10","unstructured":"GRADEpro GDT. GRADEpro guideline development tool [software]. 2015. McMaster University (developed by Evidence Prime, Inc). Available at: gradepro.org. Accessed March 15, 2017."},{"key":"10.1016\/j.cgh.2018.01.021_bib11","first-page":"1","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.cgh.2018.01.021_bib12","series-title":"R: A language and environment for statistical computing","article-title":"R\u00a0Development Core Team","year":"2011"},{"key":"10.1016\/j.cgh.2018.01.021_bib13","series-title":"Statistical methods for meta-analysis","author":"Hedges","year":"1985"},{"key":"10.1016\/j.cgh.2018.01.021_bib14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2018.01.021_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2018.01.021_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jama.283.3.367","article-title":"Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial","volume":"283","author":"Yuan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2018.01.021_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0885-3924(01)00369-4","article-title":"Low-dose oral naloxone reverses opioid-induced constipation and analgesia","volume":"23","author":"Liu","year":"2002","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.cgh.2018.01.021_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1517\/14656560902796798","article-title":"Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial","volume":"10","author":"L\u00f6wenstein","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cgh.2018.01.021_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpain.2008.06.012","article-title":"A\u00a0randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation","volume":"13","author":"Meissner","year":"2009","journal-title":"Eur J Pain Lond Engl"},{"key":"10.1016\/j.cgh.2018.01.021_bib20","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/pme.12775","article-title":"New formulation of sustained release naloxone can reverse opioid induced constipation without compromising the desired opioid effects","volume":"16","author":"Sanders","year":"2015","journal-title":"Pain Med"},{"key":"10.1016\/j.cgh.2018.01.021_bib21","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1185\/03007990802584454","article-title":"Fixed-ratio combination oxycodone\/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain","volume":"24","author":"Simpson","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cgh.2018.01.021_bib22","first-page":"175","article-title":"A\u00a0randomized, placebo-controlled phase 3 trial (Study SB-767905\/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain","volume":"12","author":"Irving","year":"2011","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.cgh.2018.01.021_bib23","first-page":"185","article-title":"A\u00a0randomized, placebo-controlled phase 3 trial (Study SB-767905\/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain","volume":"12","author":"Jansen","year":"2011","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.cgh.2018.01.021_bib24","first-page":"184","article-title":"Alvimopan: an\u00a0oral, peripherally acting, mu-opioid receptor antagonist for\u00a0the treatment of opioid-induced bowel dysfunction\u2013a 21-day treatment-randomized clinical trial","volume":"6","author":"Paulson","year":"2005","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.cgh.2018.01.021_bib25","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pain.2007.11.008","volume":"137","author":"Webster","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.cgh.2018.01.021_bib26","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1310246","article-title":"Naloxegol for opioid-induced constipation in patients with noncancer pain","volume":"370","author":"Chey","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2018.01.021_bib27","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.pain.2013.04.024","article-title":"A\u00a0phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation","volume":"154","author":"Webster","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.cgh.2018.01.021_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jhm.943","article-title":"Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery","volume":"7","author":"Anissian","year":"2012","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.cgh.2018.01.021_bib29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/jpm.2014.0362","article-title":"Fixed-dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: results of a randomized, placebo-controlled study and open-label extension","volume":"18","author":"Bull","year":"2015","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.cgh.2018.01.021_bib30","first-page":"554","article-title":"Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study","volume":"12","author":"Michna","year":"2011","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.cgh.2018.01.021_bib31","first-page":"39","article-title":"Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients","volume":"7","author":"Slatkin","year":"2009","journal-title":"J\u00a0Support Oncol"},{"key":"10.1016\/j.cgh.2018.01.021_bib32","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1056\/NEJMoa0707377","article-title":"Methylnaltrexone for opioid-induced constipation in advanced illness","volume":"358","author":"Thomas","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2018.01.021_bib33","doi-asserted-by":"crossref","first-page":"1466P","DOI":"10.1093\/annonc\/mdw390.34","article-title":"Treatment of opioid-induced constipation with naldemedine in patients with cancer: onset of action in a randomized phase 3 trial","volume":"27","author":"Murata","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cgh.2018.01.021_bib34","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/S0016-5085(16)30515-7","article-title":"598 efficacy and safety of naldemedine for the treatment of opioid-induced constipation in subjects with chronic non-cancer pain receiving opioid therapy: results from two phase 3 clinical trials","volume":"150","author":"Hale","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2018.01.021_bib35","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1093\/pm\/pnw325","article-title":"A phase 2b, randomized, double-blind placebo-controlled study to evaluate the efficacy and safety of naldemedine for the treatment of opioid-induced constipation in patients with chronic noncancer pain","volume":"18","author":"Webster","year":"2017","journal-title":"Pain Med"},{"key":"10.1016\/j.cgh.2018.01.021_bib36","first-page":"S77","article-title":"TD-1211 demonstrates a durable increase in bowel movement frequency and return toward normal bowel function in a 5-week PH2B opioid-induced constipation (OIC) study","volume":"15","author":"Vickery","year":"2014","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.cgh.2018.01.021_bib37","unstructured":"Spierings E. Opioid-induced bowel dysfunction pivotal assessment of lubiprostone (OPAL). Available at: www.clinicaltrials.gov. Accessed November 17, 2016."},{"key":"10.1016\/j.cgh.2018.01.021_bib38","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/pme.12437","article-title":"A\u00a0randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain","volume":"15","author":"Cryer","year":"2014","journal-title":"Pain Med"},{"key":"10.1016\/j.cgh.2018.01.021_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ajg.2015.106","article-title":"A\u00a0randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain","volume":"110","author":"Jamal","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2018.01.021_bib40","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1007\/s10620-010-1229-y","article-title":"Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation","volume":"55","author":"Sloots","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2018.01.021_bib41","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/papr.12535","article-title":"Randomized, double-blind trial of oral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic noncancer pain","volume":"17","author":"Rauck","year":"2017","journal-title":"Pain Pract"},{"key":"10.1016\/j.cgh.2018.01.021_bib42","first-page":"CD003448","article-title":"Laxatives for the management of constipation in people receiving palliative care","volume":"5","author":"Candy","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2018.01.021_bib43","first-page":"CD003448","article-title":"Laxatives or methylnaltrexone for the management of constipation in palliative care patients","volume":"1","author":"Candy","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2018.01.021_bib44","first-page":"1837","article-title":"Opioid-induced constipation and bowel dysfunction: a clinical guideline","volume":"18","author":"M\u00fcller-Lissner","year":"2017","journal-title":"Pain Med"},{"key":"10.1016\/j.cgh.2018.01.021_bib45","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1111\/pme.12937","article-title":"Consensus recommendations on initiating prescription therapies for opioid-induced constipation","volume":"16","author":"Argoff","year":"2015","journal-title":"Pain Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356518300879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356518300879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:25:24Z","timestamp":1761542724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356518300879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1542356518300879"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2018.01.021","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2018.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the AGA Institute","name":"copyright","label":"Copyright"}]}}